Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area
Abeona Therapeutics Inc Nasdaq ABEO has revealed its plans to move forward with submitting a Biologics License Application BLA to the US Food and Drug Administration FDA for EB an investigative autologous engineered cell therapy aimed at patients wit...
Altasciences has announced the successful completion of a Phase I trial evaluating Ischemix Incs novel cytoprotective drug candidate CMX intended for the treatment of acute traumatic brain injury TBI
TScan Therapeutics Inc a company listed on Nasdaq as TCRX and focused on advancing T cell receptorengineered T cell therapies TCRT for cancer has declared that the US Food and Drug Administration FDA has granted approval for its investigational new d...
Mitsubishi Tanabe Pharma Canadas subsidiary MTPCA has announced that RADICAVA Oral Suspension edaravone has been included in the New Brunswick Drug Plan NBDP formulary with special authorization and the Nova Scotia Formulary with exceptional status
Certara listed on Nasdaq as CERT an influential figure in the field of biosimulation has recently disclosed that the Simcyp group is the recipient of two novel grants from the US Food and Drug Administration FDA
Atsena Therapeutics has achieved a significant milestone in its pursuit of treating Xlinked retinoschisis XLRS a genetic eye disorder The company has announced the dosing of the first patient in its Phase III clinical trial known as the LIGHTHOUSE st...
BridGene Biosciences Inc has made a significant advancement in its collaboration with Takeda a biopharmaceutical company The company employs a proprietary technology called IMTAC Isobaric Mass Tagged Affinity Characterization which focuses on identif...
Valneva SE a company specializing in vaccine development has shared promising results from the early Phase safety evaluation of its chikungunya CHIKV vaccine candidate VLA in adolescents The study denoted as VLA
Nura Bio a biopharmaceutical company dedicated to developing small molecule therapies for debilitating neurological diseases has announced the commencement of Phase clinical trials for NB its SARM inhibitor This marks a significant step forward in t...
Taysha Gene Therapies Inc has been granted Fast Track Designation FTD by the US FDA for TSHA its AAV gene transfer therapy developed to treat Rett syndrome Rett syndrome is a rare neurodevelopmental disorder caused by mutations in the MECP gene resul...
